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MOUSE orthotopic liver allografts are spontaneously 
accepted without immunosuppression in many 
strain combinations including those crossing major and 
minor histoincompatibility barriers. Liver allograft accep-
tance, moreover. leads to donor-specific acceptance of 
subsequent skin or heart allografts. Although the precise 
mechanisms of liver graft tolerance (LGT) are not com-
pletely understood. LGT has been attributed to: (1) donor 
nonparenchymal cell (NPC) migration leading to subse-
quent recipient/donor hematolymphoid chimerism lK~; and 
(2) hepatocyte (HC) release of soluble MHC molecules.3 
We have used an experimental model. similar in principle 
to that of Rapaport et aV and used previously by Sriwa-
tanawongsa et al5 to test whether the NPC or HC was the 
more important component in LGT by constructing chi-
meric donor livers whose NPC have been replaced by 
allogeneic bone marrow transplantation (BMT). 
MATERIALS AND METHODS 
liver donor mice (H-2") were supralethally irradiated (9.5 Gy) and 
reconstituted via tail-vein injection with 1.5 x 10" syngeneic (H_2h), 
or fully allogeneic liver recipient type (H_2 k ). and third party (H-2") 
whole bone marrow cells harvested from mouse femur and tibia. 
Ninety days (90) days after BMT. splenocytes and peripheral blood 
mononuclear cells (PBMC) were phenotyped for recipient/donor 
cells by ftow cytometry, and liver by immunohistochemistry. A 
mixed leukocyte reaction was also done to assess immune status in 
chimeric liver donor animals. Ninety-day-old chimeric donor liver 
I1'Ifts were transplanted according to techniques by Oian et al2 into 
untreated naive H-2' recipients and challenged with H_2h and H_2d 
akin grafts 30 days after transplantation (Table I) or on the same 
day as liver transplantation (Table 2). Two combinations of mouse 
Itrains were analyzed: (I) The C57BUIO (H-2"), BALB/c (H_2d), 
and C3H (H_2k) combination, which crosses all major and minor 
bistoincompatibility barriers; and (2) the congenic C57BUlO, 
810.D2 (H-2d ), and BIO.BR (H_2k), which cross all major loci. 
RESULTS AND DISCUSSION 
The donor preparation resulted in >99% replacement of 
PBMC and splenocytes with cells of bone marrow donor 
origin 90 days after BMT as determined by flow cytometry. 
Liver phenotyping by immunohistochemical staining with 
class I and II specific antibodies showed hepatocytes and 
bile duct cells to be of bone marrow recipient haplotype. 
while NPC to be >99% of bone marrow donor haplotype. 
However. rare residual NPC from the original liver per-
sisted. At 90 days. chimeric animals also showed specific 
unresponsiveness to bone marrow donor and recipient 
haplotypes but not to third party as determined by the 
mixed leukocyte culture. suggesting immunological donor-
recipient stability in these chimeras. 
The transplantation of chimeric donor livers with either 
NPC of donor (H-2"). third-party (H-2"). or liver recipient 
(H-2k) haplotype resulted in spontaneous acceptance of 
liver grafts in either of the combinations of mouse strains. 
However. the donor-specific tolerance normally induced for 
C57BUlO skin by the unaltered C57BUIO liver in this 
model (see Qian et all and group I of Table 1) was no 
longer evident when the donor livers were taken from 
irradiated animals that had been reconstituted with synge-
neic (C57BUIO) bone marrow. This suggested that the liver 
NPC (or some other factor in the organ) had been changed 
in the first stages of these control experiments. The reduced 
skin graft protection was now no different than when the 
donor NPC were converted to those of the recipient (group 
4) or to a third party (group 3). Although the skin survival 
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Table 1. Tolerance Induction of Donor Skin by Chimeric Livers in Mouse Liver Transplantation in C57BLl10, BALB/c. 
C3H Combinations 
Donor liver Skin Graft Survival (Days)" 
Group NPC HC Recipient C57BU10' BALB/c' 
1 Normal C57BU10 Normal C57BU10 C3H 71,80. >100. >100. >100 16, 17. 17,23 
2 C57BU10 C57BU10 C3H 29, 35, 44, 47, 86 15,17,19,20 
3 BALB/c C57BU10 C3H 44, 45, 46. 48 16, 17,20 
4 C3H C57BU10 C3H 34, 50, 53. 56 12.12. 14. 14 
"lIoIated skin graft survival In the unaltered C3H recipient IS 9to 10 days uSing C57BU10 donor. 9 to 10 days With BALB/c. and permanent With C3H. 
'Skin grafts 30 days after liver transplantation. 
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Table 2. Tolerance Induction of Donor Skin by Chimeric Livera In Mouse Uver TranS!)lantation in C57BLJ10, B10.BR B10.BR, 
B10.D2 Combinations 
Donor liver Skin Graft Survival (Days)' 
Group NPC HC Recipient C57BU10' B10.D2' 
5 Normal C57BU10 Normal C57BU10 B10.BR >100. >100. >100 
6 C57BU10 C57BU10 B10.SR >100. >100. >100 28. 30. 16 
7 B10.02 C57BU10 S10.SR 30.20. >100. >100. >100 28.19.21.20.21 
8 S10.SR C57BU10 S10.SR 24.25. >100. >100 22.21.17.17.20 
'Isolated skin graft survival on the una~ered B10.BR recipient IS 12 to 14 days uSing C57BU10 donor. 12 to 14 days with BALBIc. and permanent with C3H. 
'Skin grafts placed on the same day as liver transplantation. 
was indistinguishable. it was modestly prolonged in all 
compared to that of an isolated skin graft in the same strain 
combinations (see footnote to Table I). Similarly, the 
animals bearing transplanted "parked" livers rejected 
BALB/c skin without regard for the strain used to repopu-
late the hepatic graft donor, but at a pace of rejection that 
again was marginally slower than that expected in these 
strains after a conventional isolated skin graft (see footnote 
to Table I). 
The MHC nonspecificity of these results is self-evident. 
The possibility that a procedural timing factor was respon-
sible prompted further experiments using fully allogeneic 
C57BUlO ..... BlO.BR mice. With this strain combination, 
transplantation of an unmodified liver confers specific 
tolerance to concomitantly transplanted donor skin (see 
Qian et at2 and group I of Table I). Unlike the controls in 
Table I, donor-irradiated and syngeneic reconstitution did 
not cause loss of specific tolerance to the concomitantly 
engrafted skin grafts (group 2, Table I). This reaction 
increased the importance of the experiments in group 3 in 
which the C57BUlO liver donor was reconstituted with 
third-party NPC (BIO.D2) and group 4 in which the recon-
stitution was with recipient leukocytes (BIO.BR). Skin 
acceptance was expected in group 4 but not group 3 if 
hepatocytes were potently tolerogenic. However, 40% of 
the skin grafts in both groups were rejected in 20 to 30 days 
(Table 2). In addition, C57BUIO livers reconstituted with 
81O.D2 NPC did not prevent rejection of BI0.D2 skin 
suggesting that hepatic tolerogenicity for skin could not be 
attributed to NPC alone under these experimental circum-
stances. 
These results are largely confirmatory of recent observa-
tions by Caine et a15 •H in rats, differing only in that the 
hepatocyte effect appears to us MHC nonspecific. In com-
mon with the findings of the Cambridge team, there was a 
dissociation of liver graft acceptance from tolerance to skin, 
analogous perhaps to the survival of NPC-free islets in-
jected into the mouse thymus but without the systemic 
donor-specific tolerance that is produced by unmodified 
islets. As discussed before. there is room for speculation 
about parenchymal-non parenchymal cell collaboration in 
the events of tolerance or other immune eventsKRKeK~ indud-
ing the cross-regulation of immunologic and growth factor 
networks. 10 
As we have discussed earlier. I I the "parking" experimen-
tal models may not be appropriate for such inquiries. The 
rationale for their use to investigate tolerance mechanisms 
has faded in the face of mounting evidence that transplan-
tation tolerance is the product of a two-way immunologic 
transaction (graft versus host as well as host versus graft). 
When an organ has been parked and is stable in the.: 
intermediary host. both graft and recipients have exchanged 
NPC and have genetic composites.I.2.b.7.9.11 The organ 
already is tolerant to the carrier animal and vice versa. with 
a mixed NPC population in both that presumably has 
manifold changes (particularly in gene expression). Only at 
this time is the organ extirpated from the immunologic 
network into which its mini-immune system has been 
assimilated. Because we believe that these changes define 
per se the molecular secrets of tolerance, it is not surprising 
that the use of such an organ to study tolerance de novo in 
a new recipient has yielded confusing and perhaps mislead-
ing information. 
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